Forward Therapeutics
PrivateLast Round
Series A
Oct 31, 2023
Total Funding Raised
$58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Forward Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in October 2023.
Forward Therapeutics is a biotechnology company that develops oral small-molecule therapies for the treatment of inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forward Therapeutics Comparables
Compare Forward Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PsiThera | 89% | |
| Evommune | 82% | |
| Incyte Corporation | 81% |
For institutional investors. Book with your work email.
Forward Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2023 | ||||
| Seed | May 1, 2022 |
For institutional investors. Book with your work email.
Forward Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| OrbiMed | Series A |
| BVF Partners L.P. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 300% MoM, reaching 1.8K.
- Apr 18, 2026
Monthly visitors increased 42% MoM, from 757 to 1.1K.
For institutional investors. Book with your work email.
Forward Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Forward Therapeutics's valuation, stock price, and market status.
Is Forward Therapeutics a public or private company?
Forward Therapeutics is a private company.
What is the current stock price of Forward Therapeutics?
Forward Therapeutics is a private company, so its shares have no public market price. Caplight tracks Forward Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Forward Therapeutics worth (valuation)?
Valuation information for Forward Therapeutics is not publicly available.
Can I buy Forward Therapeutics stock?
Forward Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Forward Therapeutics's last funding round?
Forward Therapeutics's most recent funding round was Series A on October 31, 2023.
Who are the main investors in Forward Therapeutics?
Key investors in Forward Therapeutics include BVF Partners L.P..
Will Forward Therapeutics IPO soon?
No public IPO plans have been announced for Forward Therapeutics.
How can I track Forward Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Forward Therapeutics's shares on secondary markets.